Perrigo to sell generic drugs business for $1.55 billion

Perrigo to sell generic drugs business for $1.55 billion

Perrigo Company on Monday posted quarterly earnings below estimates and said it would sell its underperforming generic drugs business for $1.55 billion, as the consumer healthcare products company sharpens focus on its core business. The sale, to private equity firm...